AstraZeneca A.B.
Patent Applications and Registrations
Patent applications and USPTO patent grants for AstraZeneca A.B..The latest application filed is for "assays for fprl-1 ligands".
- AstraZeneca A.B. - Sodertalje SE
- AstraZeneca A B - Sodertalje SE SE-151 85
- AstraZeneca A B -
- AstraZeneca A B - R & D Headquarters Global Intellectual Property Sodertalje SE
- AstraZeneca A B - R & D Headquartes Global Intellectual Patents Sodertalje SE
| Patent | Date |
|---|---|
| Galanin receptor 2 proteins and nucleic acids Grant 7,375,207 - Shen , et al. May 20, 2 | 2008-05-20 |
| Aqueous dispersion comprising stable nanoparticles of a water-insoluble thiazole derivative and excipients like middle chain triglycerides App 20060141043 - Lindfors; Lennart | 2006-06-29 |
| Assays for fprl-1 ligands App 20060141460 - Henderson; Duncan ; et al. | 2006-06-29 |
| Splice variant cannabinoid receptor (cb1b) App 20060115816 - Vu; Huy Khang ; et al. | 2006-06-01 |
| Use of and some novel imidazopyridines App 20050261333 - Johansson, Henrik ; et al. | 2005-11-24 |
| Methods to identify true antagonists and inverse agonists of the cannabinoid receptor App 20050239133 - Greasley, Peter | 2005-10-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 